Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Morava

Showing results (231-240 of 355) with videos related to

Pageof 36
Sort By:
The Journal of Pediatrics|September 17, 2011
B4GALT1-congenital disorders of glycosylation presents as a non-neurologic glycosylation disorder with hepatointestinal involvementMaïlys Guillard, Eva Morava, Jorg de Ruijter, et al.
Molecular Genetics and Metabolism|December 4, 2014
Cerebral lipid accumulation in Chanarin-Dorfman SyndromeMarleen C D G Huigen, Marinette van der Graaf, Eva Morava, et al.
Molecular Genetics and Metabolism|May 4, 2024
ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelinesRameen Shah, Erik A Eklund, Silvia Radenkovic, et al.
American Journal of Medical Genetics. Part A|November 14, 2008
Recurrent rhabdomyolysis in a patient with oculocutaneous albinism type 1 and platelet storage-pool deficiencyDespina Contopoulos-Ioannidis, Athanasios Evangeliou, Henk ter Laak, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?Peter Witters, Tomas Honzik, Eric Bauchart, et al.
Molecular Genetics and Metabolism|May 12, 2024
D-mannose as a new therapy for fucokinase deficiency-related congenital disorder of glycosylation (FCSK-CDG)Rodrigo Tzovenos Starosta, Angela J Lee, Elizabeth R Toolan, et al.
Kidney International Reports|June 17, 2026
Enrichment of Rare Mitochondrial DNA Variants Among Individuals With Kidney Disease Reveals Undiagnosed Mitochondrial DiseaseDaniel R Schecter, Rory J Tinker, Patrick O'Connell, et al.
Genes|August 26, 2023
Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDGAnna N Ligezka, Rohit Budhraja, Yurika Nishiyama, et al.
Frontiers in Genetics|May 21, 2024
Case report: Novel genotype of ALG2-CDG and confirmation of the heptasaccharide glycan (NeuAc-Gal-GlcNAc-Man2-GlcNAc2) as a specific diagnostic biomarkerIvan Martínez Duncker, Denisse Mata-Salgado, Ibrahim Shammas, et al.
Biochemical and Biophysical Research Communications|July 31, 2007
Null mutations and lethal congenital form of glycogen storage disease type IVStefania Assereto, Otto P van Diggelen, Luisa Diogo, et al.
Pageof 36

Showing results (231-240 of 355) with videos related to

Sort By:
Pageof 36
The Journal of Pediatrics|September 17, 2011
B4GALT1-congenital disorders of glycosylation presents as a non-neurologic glycosylation disorder with hepatointestinal involvementMaïlys Guillard, Eva Morava, Jorg de Ruijter, et al.
Molecular Genetics and Metabolism|December 4, 2014
Cerebral lipid accumulation in Chanarin-Dorfman SyndromeMarleen C D G Huigen, Marinette van der Graaf, Eva Morava, et al.
Molecular Genetics and Metabolism|May 4, 2024
ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelinesRameen Shah, Erik A Eklund, Silvia Radenkovic, et al.
American Journal of Medical Genetics. Part A|November 14, 2008
Recurrent rhabdomyolysis in a patient with oculocutaneous albinism type 1 and platelet storage-pool deficiencyDespina Contopoulos-Ioannidis, Athanasios Evangeliou, Henk ter Laak, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?Peter Witters, Tomas Honzik, Eric Bauchart, et al.
Molecular Genetics and Metabolism|May 12, 2024
D-mannose as a new therapy for fucokinase deficiency-related congenital disorder of glycosylation (FCSK-CDG)Rodrigo Tzovenos Starosta, Angela J Lee, Elizabeth R Toolan, et al.
Kidney International Reports|June 17, 2026
Enrichment of Rare Mitochondrial DNA Variants Among Individuals With Kidney Disease Reveals Undiagnosed Mitochondrial DiseaseDaniel R Schecter, Rory J Tinker, Patrick O'Connell, et al.
Genes|August 26, 2023
Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDGAnna N Ligezka, Rohit Budhraja, Yurika Nishiyama, et al.
Frontiers in Genetics|May 21, 2024
Case report: Novel genotype of ALG2-CDG and confirmation of the heptasaccharide glycan (NeuAc-Gal-GlcNAc-Man2-GlcNAc2) as a specific diagnostic biomarkerIvan Martínez Duncker, Denisse Mata-Salgado, Ibrahim Shammas, et al.
Biochemical and Biophysical Research Communications|July 31, 2007
Null mutations and lethal congenital form of glycogen storage disease type IVStefania Assereto, Otto P van Diggelen, Luisa Diogo, et al.
Pageof 36